Free webinar at 1 p.m. Eastern time (US), Wednesday, November 1, 2023
Learn research updates about how Microbiota Transfer Therapy—and its possible interactions with bacteria—may impact gastrointestinal and autism-related symptoms in adults.
Microbiota Transfer Therapy and Autism
Dr. Rosa Krajmalnik-Brown is an Associate Professor at the School of Sustainable Engineering and The Built Environment and the Swette Center for Environmental Biotechnology at Arizona State University. She Joined the SSEBE faculty in 2007. She has Ph.D. in Environmental Engineering from Georgia Tech. She was awarded an NSF CAREER award, was selected as one of 40 under 40 leaders in Phoenix, AZ. Funding for her research has come from many federal agencies including NIH, DoE, DoD, and NSF. She pioneers research on gut microbiome and autism and is the author of 3 patents and more than 90 peer-reviewed publications.
Dr. Krajmalnik-Brown specializes in molecular microbial ecology for bioremediation, the use of microbial systems for bioenergy production, and the human intestinal microbial ecology and its relationship to obesity, bariatric surgery, and autism.
Microbiota Transfer Therapy Research Updates – Adults
Free webinar at 1 p.m. Eastern time (US), Wednesday, November 1, 2023 Learn research updates about how Microbiota Transfer Therapy—and its possible interactions with bacteria—may impact gastrointestinal and autism-related symptoms in adults.
Microbiota therapy may lead to lasting beneficial changes in the gut health of children with autism
Microbiota transfer therapy (MTT) may lead to long-term improvements in the gut health of children with autism spectrum disorders (ASD), according to a recent study by Khemlal Nirmalkar and colleagues at
Gastrointestinal Symptoms in Autistic Patients
Federico Balzola, MD, shares findings on gastrointestinal symptoms and pathological microscopic histological alterations found during upper and lower endoscopy with biopsies in more than 400 patients with autism.
Co-Occurring Conditions and Autism
Research suggests that individuals with autism experience some conditions―including underlying medical issues, neurodevelopmental differences, and mental health issues―more frequently than the general population. Learning about these potential medical needs can help you
Researchers find clues to inconsistent microbiome findings in ASD, see longitudinal effects
A new study suggests that changes occurring over time in the behavior of individuals with autism spectrum disorders (ASD) may be related to their gut microbiomes. In addition, it offers insights
New animal research offers insights into the effects of the microbiome on social deficits in ASD
A new study provides additional clues about the role the gut microbiome may play in autism spectrum disorders (ASD). In earlier research (see ARRI 2019, Volume 1), Mauro Costa-Mattioli and colleagues